ACE and Alzheimer disease: In patients with AD, cerebrospinal fluid (CSF) levels of ACE were reduced in comparison with controls and correlated with reduced amyloid-β (Aβ)42 levels, which indicates increased Aβ amyloid accumulation in the brain, a known indicator of AD burden (Rocha et al., 2018).